Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

We successfully synthesized a novel peroxisome proliferator-activated receptor (PPAR)δ selective agonist, namely, compound 20, with a characteristic benzisoxazole ring. Compound 20 exhibited potent human PPARδ transactivation activity and high δ selectivity. Further, it stimulated differentiation of primary oligodendrocyte precursor cells in vitro, indicating that it may be an effective drug in the treatment of demyelinating disorders such as multiple sclerosis.

Knowledge Graph

Similar Paper

Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation
Bioorganic & Medicinal Chemistry Letters 2011.0
Biological evaluation of novel benzisoxazole derivatives as PPARδ agonists
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis
Journal of Medicinal Chemistry 2021.0
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist
Journal of Natural Products 2016.0
Identification and Synthesis of a Novel Selective Partial PPARδ Agonist with Full Efficacy on Lipid Metabolism In Vitro and In Vivo
Journal of Medicinal Chemistry 2007.0
Design and Synthesis of Dual Peroxisome Proliferator-Activated Receptors γ and δ Agonists as Novel Euglycemic Agents with a Reduced Weight Gain Profile
Journal of Medicinal Chemistry 2006.0
Discovery and structure-based design of a new series of potent and selective PPARδ agonists utilizing a virtual screening method
Bioorganic & Medicinal Chemistry Letters 2022.0
Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists
Bioorganic & Medicinal Chemistry Letters 2003.0
Selective peroxisome proliferator-activated receptor δ isosteric selenium agonists as potent anti-atherogenic agents in vivo
Bioorganic & Medicinal Chemistry Letters 2010.0